Characterization of the cardiac response to a low and high dose of dobutamine in the mouse model of dilated cardiomyopathy by MRI in vivo

Journal of Magnetic Resonance Imaging

Volumn 37, Issue 3, 2013, Pages 669-677

  Tyrankiewicz, Urszula ^a   Skorka, Tomasz ^a   Jablonska, Magdalena ^a,b   Petkow Dimitrow, Pawel ^c   Chlopicki, Stefan ^c,d  

^a INSTITUTE OF NUCLEAR PHYSICS   (Poland)

^b AGH UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Poland)

^c JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

^d JAGIELLONIAN UNIVERSITY   (Poland)

Author keywords

cardiac ischemia; dobutamine; heart failure; mice; MRI

Indexed keywords

DOBUTAMINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BETA ADRENERGIC STIMULATION; CHRONOTROPISM; CONGESTIVE CARDIOMYOPATHY; CONTROLLED STUDY; DISEASE COURSE; DOSE RESPONSE; DRUG MEGADOSE; ELECTROCARDIOGRAM; HEART FAILURE; HEART FUNCTION; HEART LEFT VENTRICLE FUNCTION; HEART PERFORMANCE; HEART RATE; IN VIVO STUDY; INOTROPISM; LOW DRUG DOSE; LUSITROPISM; MOUSE; MUSCLE CHARACTERISTICS AND FUNCTIONS; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; PRIORITY JOURNAL; TREATMENT RESPONSE; WILD TYPE;

ADRENERGIC BETA-1 RECEPTOR AGONISTS; ANIMALS; CARDIOMYOPATHY, DILATED; DISEASE MODELS, ANIMAL; DOBUTAMINE; ELECTROCARDIOGRAPHY; HEART; HEART FAILURE; HEART RATE; MAGNETIC RESONANCE IMAGING; MICE; MYOCARDIUM; RECEPTORS, ADRENERGIC, BETA; SOFTWARE; VENTRICULAR FUNCTION, LEFT;

EID: 84874224335     PISSN: 10531807     EISSN: 15222586     Source Type: Journal    
DOI: 10.1002/jmri.23854     Document Type: Article

References (40)

1. Dickstein K, Cohen-Solal A, Filippatos G, et al. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the diagnosis and treatment of acute and chronic heart failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM). Eur J Heart Fail 2008; 10: 933-989.
2. Tuttle RR, Mills J,. Dobutamine: development of a new catecholamine to selectively increase cardiac contractility. Circ Res 1975; 36: 185-196.
3. Schinkel AF, Poldermans D, Elhendy A, Bax JJ,. Assessment of myocardial viability in patients with heart failure. J Nucl Med 2007; 48: 1135-1146.
4. Hyodo E, Muro T, Hozumi T, et al. Observation of the ischemic cascade in humans using contrast echocardiography during dobutamine stress. Circ J 2003; 67: 406-410.
5. Fowler MB, Laser JA, Hopkins GL, Minobe W, Bristow MR,. Assessment of the beta-adrenergic receptor pathway in the intact failing human heart: progressive receptor down-regulation and subsensitivity to agonist response. Circulation 1986; 74: 1290-1302.
6. Koba W, Kim K, Lipton ML, et al. Imaging devices for use in small animals. Semin Nucl Med 2011; 41: 151-165.
7. Tsui BM, Kraitchman DL,. Recent advances in small-animal cardiovascular imaging. J Nucl Med 2009; 50: 667-670.
8. Wiesmann F, Ruff J, Engelhardt S, et al. Dobutamine-stress magnetic resonance microimaging in mice: acute changes of cardiac geometry and function in normal and failing murine hearts. Circ Res 2001; 88: 563-569.
9. Song W, Dyer E, Stuckey D, et al. Investigation of a transgenic mouse model of familial dilated cardiomyopathy. J Mol Cell Cardiol 2010; 49: 380-389.
10. Williams SP, Gerber HP, Giordano FJ, et al. Dobutamine stress cine-MRI of cardiac function in the hearts of adult cardiomyocyte-specific VEGF knockout mice. J Magn Reson Imaging 2001; 14: 374-382.
11. ten HM, Lygate CA, Fischer A, et al. Reduced inotropic reserve and increased susceptibility to cardiac ischemia/reperfusion injury in phosphocreatine-deficient guanidinoacetate-N-methyltransferase-knockout mice. Circulation 2005; 111: 2477-2485.
12. Vandsburger MH, French BA, Helm PA, et al. Multi-parameter in vivo cardiac magnetic resonance imaging demonstrates normal perfusion reserve despite severely attenuated beta-adrenergic functional response in neuronal nitric oxide synthase knockout mice. Eur Heart J 2007; 28: 2792-2798.
13. Drelicharz L, Wozniak M, Skorka T, et al. Application of magnetic resonance imaging in vivo for the assessment of the progression of systolic and diastolic dysfunction in a mouse model of dilated cardiomyopathy. Kardiol Pol 2009; 67: 386-395.
14. Edes IF, Toth A, Csanyi G, et al. Late-stage alterations in myofibrillar contractile function in a transgenic mouse model of dilated cardiomyopathy (Tgalphaq*44). J Mol Cell Cardiol 2008; 45: 363-372.
15. Elas M, Bielanska J, Pustelny K, et al. Detection of mitochondrial dysfunction by EPR technique in mouse model of dilated cardiomyopathy. Free Radic Biol Med 2008; 45: 321-328.
16. Mende U, Semsarian C, Martins DC, et al. Dilated cardiomyopathy in two transgenic mouse lines expressing activated G protein alpha(q): lack of correlation between phospholipase C activation and the phenotype. J Mol Cell Cardiol 2001; 33: 1477-1491.
17. Berry CJ, Thedens DR, Light-McGroary K, et al. Effects of deep sedation or general anesthesia on cardiac function in mice undergoing cardiovascular magnetic resonance. J Cardiovasc Magn Reson 2009; 11: 16.
18. Kober F, Iltis I, Cozzone PJ, Bernard M,. Myocardial blood flow mapping in mice using high-resolution spin labeling magnetic resonance imaging: influence of ketamine/xylazine and isoflurane anesthesia. Magn Reson Med 2005; 53: 601-606.
19. Schiller NB, Shah PM, Crawford M, et al. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms. J Am Soc Echocardiogr 1989; 2: 358-367.
20. Bokov AF, Lindsey ML, Khodr C, Sabia MR, Richardson A,. Long-lived ames dwarf mice are resistant to chemical stressors. J Gerontol A Biol Sci Med Sci 2009; 64: 819-827.
21. Plante E, Lachance D, Drolet MC, Roussel E, Couet J, Arsenault M,. Dobutamine stress echocardiography in healthy adult male rats. Cardiovasc Ultrasound 2005; 3: 34.
22. de Jong RM, Cornel JH, Crijns HJ, van Veldhuisen DJ,. Abnormal contractile responses during dobutamine stress echocardiography in patients with idiopathic dilated cardiomyopathy. Eur J Heart Fail 2001; 3: 429-436.
23. Senior R, Lahiri A,. Enhanced detection of myocardial ischemia by stress dobutamine echocardiography utilizing the "biphasic" response of wall thickening during low and high dose dobutamine infusion. J Am Coll Cardiol 1995; 26: 26-32.
24. Drelicharz L, Kozlovski V, Skorka T, et al. NO and PGI(2) in coronary endothelial dysfunction in transgenic mice with dilated cardiomyopathy. Basic Res Cardiol 2008; 103: 417-430.
25. Mackiewicz U, Klemenska E, Beresewicz A,. Beta-adrenergic receptors in normal and failing heart. Kardiol Pol 2007; 65: 294-302.
26. Montgomery DE, Rundell VL, Goldspink PH, et al. Protein kinase C epsilon induces systolic cardiac failure marked by exhausted inotropic reserve and intact Frank-Starling mechanism. Am J Physiol Heart Circ Physiol 2005; 289: H1881-H1888.
27. Shai SY, Harpf AE, Babbitt CJ, et al. Cardiac myocyte-specific excision of the beta1 integrin gene results in myocardial fibrosis and cardiac failure. Circ Res 2002; 90: 458-464.
28. Zhang T, Johnson EN, Gu Y, et al. The cardiac-specific nuclear delta(B) isoform of Ca2+/calmodulin-dependent protein kinase II induces hypertrophy and dilated cardiomyopathy associated with increased protein phosphatase 2A activity. J Biol Chem 2002; 277: 1261-1267.
29. Bauer R, MacGowan GA, Blain A, Bushby K, Straub V,. Steroid treatment causes deterioration of myocardial function in the δ-sarcoglycan-deficient mouse model for dilated cardiomyopathy. Cardiovasc Res 2008; 79: 652-661.
30. D'Angelo DD, Sakata Y, Lorenz JN, et al. Transgenic Galphaq overexpression induces cardiac contractile failure in mice. Proc Natl Acad Sci U S A 1997; 94: 8121-8126.
31. Rajagopalan V, Zucker IH, Jones JA, Carlson M, Ma YJ,. Cardiac ErbB-1/ErbB-2 mutant expression in young adult mice leads to cardiac dysfunction. Am J Physiol Heart Circ Physiol 2008; 295: H543-H554.
32. Dessy C, Balligand JL,. Beta3-adrenergic receptors in cardiac and vascular tissues emerging concepts and therapeutic perspectives. Adv Pharmacol 2010; 59: 135-163.
33. Barouch LA, Harrison RW, Skaf MW, et al. Nitric oxide regulates the heart by spatial confinement of nitric oxide synthase isoforms. Nature 2002; 416: 337-339.
34. Damy T, Ratajczak P, Shah AM, et al. Increased neuronal nitric oxide synthase-derived NO production in the failing human heart. Lancet 2004; 363: 1365-1367.
35. Dawson D, Lygate CA, Zhang MH, Hulbert K, Neubauer S, Casadei B,. nNOS gene deletion exacerbates pathological left ventricular remodeling and functional deterioration after myocardial infarction. Circulation 2005; 112: 3729-3737.
36. Bendall JK, Alp NJ, Warrick N, et al. Stoichiometric relationships between endothelial tetrahydrobiopterin, endothelial NO synthase (eNOS) activity, and eNOS coupling in vivo: insights from transgenic mice with endothelial-targeted GTP cyclohydrolase 1 and eNOS overexpression. Circ Res 2005; 97: 864-871.
37. Casadei B,. The emerging role of neuronal nitric oxide synthase in the regulation of myocardial function. Exp Physiol 2006; 91: 943-955.
38. Godecke A, Decking UK, Ding Z, et al. Coronary hemodynamics in endothelial NO synthase knockout mice. Circ Res 1998; 82: 186-194.
39. Suman OE, Hasten D, Turner MJ, Rinder MR, Spina RJ, Ehsani AA,. Enhanced inotropic response to dobutamine in strength-trained subjects with left ventricular hypertrophy. J Appl Physiol 2000; 88: 534-539.
40. Li W, Liu W, Zhong J, Yu X,. Early manifestation of alteration in cardiac function in dystrophin deficient mdx mouse using 3D CMR tagging. J Cardiovasc Magn Reson 2009; 11: 40.